Pandemic Preparedness. How will the international accord help respond to unforeseen shocks?
Science|Business organised a roundtable discussion with international experts -representing industry, academia, public health bodies, think tanks, government officials and research organisations- to discuss how to prepare for future pandemics.
Progress Report: Reducing the Burden of RSV across the Lifespan
The National Foundation for Infectious Diseases (NFID) supports RSV education by engaging key audiences, sharing firsthand experiences of RSV among all age groups, and providing resources to help raise awareness of the burden of disease.
Improving Adult Vaccination Policy in Long-Term Care Settings. Technical Report.
With the World Immunization Week coming up, IFA has produced a study to deliver critical baseline data to help inform technical guidelines, as well as governmental and civil society dialogue and policy actions, to protect the health of LTC residents.
News
Reports
Policy & Recommendations
Policy priorities for protecting adults at risk of severe illness from RSV
IFA participated in the generation of a new report by the Health Policy Partnership to build awareness of the impact of RSV in adults and highlight opportunities to reduce its burden on society through appropriate prevention, diagnosis, and care.
News
Reports
Policy & Recommendations
The European public health response to the COVID-19 pandemic: Lessons for future cross-border health threats
The early lessons from the pandemic underlined that challenges to health systems and economies, including supply chain problems and vaccine hesitancy, could no longer be overcome by European Union Member States acting alone.
Healthcare facilities should maintain and strengthen infection prevention and control measures during peaks of respiratory viruses transmission
ECDC recommends that healthcare facilities maintain and strengthen infection prevention and control measures, due to the high community transmission and co-circulation of respiratory viruses such as SARS-CoV-2, influenza, RSV and others.
The effect of communication and disinformation during the COVID-19 pandemic
This study analyses how governments, public health experts and other professionals communicated during the COVID-19 pandemic, and the impact of these communication strategies.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years
Immunity from monovalent COVID-19 mRNA vaccination wanes over time. A bivalent COVID-19 mRNA booster dose is recommended for all eligible persons; however, little is known about its effectiveness against COVID-19 hospitalization.
Life-course immunization: Country landscape report
This project was commissioned to collect evidence focused on specific life-course approach to immunization (LCI) policies and priority geographies, and to compare available data sets and case studies before and during the COVID-19 pandemic.
The Digital Pandemic: Life course immunisation in an era of fake news
Launched by the Coalition for Life Course Immunisation, the report makes recommendations for European civil society, healthcare professionals, social media and policy makers on what needs to be done to reduce the spread and impactof anti-vaccine fake news
The Health System Burden of RSV in Europe
European Health Management Association's (EHMA) white paper on the health system burden of the Respiratory syncytial virus (RSV) in Europe.